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REVISTA
BRASILEIRA DE 
ANESTESIOLOGIA
LETTER TO THE EDITOR
Case of anaphylaxis induced by 
rocuronium treated with sugammadex
Dear Editor,
First, I would like to congratulate the authors for the article 
entitled “Case of Anaphylaxis Induced by Rocuronium 
Treated with Sugammadex”, recently published in the 
Revista Brasileira de Anestesiologia (Brazilian Journal of 
Anesthesiology).1
While reading the article, two points deserving some 
considerations were noted. First, an anaphylactic reaction 
was reported after rocuronium administration; however, 
as described by the author himself, it is impossible to 
differentiate an anaphylactic from an anaphylactoid 
reaction based only on clinical data.1 Differential diagnosis 
is made by laboratory tests. The author cited an article 
reporting a similar case in which differential diagnosis was 
made, and thus the term “anaphylaxis” may use.2
The second observation relates to the time of 
medications used. In the third paragraph of the Case 
Report section, it is reported that immediately after 
intubation signs of a possible allergic reaction were noted 
and treatment initiated. Doses of epinephrine (0.30 mg) 
were used, repeated every 5 minutes, totaling 1.5 mg of 
this medication. In the next paragraph, the authors report 
that 700 mg of sugammadex were used 5 minutes after 
administration of rocuronium, followed by another dose 
of epinephrine (0.30 mg). Finally, in the fifth paragraph of 
the Discussion section, it is reported that sugammadex was 
administered 25 minutes after rocuronium.1
Thus, it is clear that there is an inconsistency in the 
administration times of medications and, hence, in total 
dose of adrenaline. Due to the great importance of the 
subject and high mortality of this complication, data 
description requires accuracy in order to become an aid 
tool for future cases.
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